02.23.21 -- Current Trends And Challenges In Clinical Trials

In 2020, the clinical trial industry adapted and responded in rapid fashion. Measures were taken to allow for continuity of studies, all while shortening timelines and ensuring safety and flexibility of care. This response by the industry was impressive and perhaps provides a glimpse into the future of clinical research. But what does the future look like?

COVID-19 has had a dramatic impact on U.S. clinical care, including how sites have worked to maintain research operations throughout the pandemic. The financial and logistical challenges faced by our site partners have been substantial. Here is a recap of the adaptations they’ve made to manage through the current environment.

The underrepresentation of certain populations in clinical research is a serious problem. However, sponsors and CROs are renewing their focus on diversity and are looking for new ways to create awareness and remove obstacles through patient-centered solutions.

Once a patient is enrolled, there are many obstacles that can impact patient retention in a study. This article discusses some of the obstacles facing oncology research today and highlights innovation opportunities to transform the way sites, sponsors, and CROs interact.

With the current clinical trial logistical challenges there comes the need for ingenuity — partnering with a travel provider who can navigate these difficult and uncertain times to ensure sustainability for the trial.